🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objective: Primary objective of the present study was to assess the relati...
Status
Completed
Location
Bio Evaluation Centre, Torrent Pharmaceuticals Ltd.,
Start Date
TBD
Trial ID
NCT01418586
Treatments Being Tested
The objectives of this study are (a) to determine if drug levels from a sin...
Status
Completed
Location
Pharmaceutical Research Unit
Start Date
2014-06
Trial ID
NCT02157649
The purpose of this study is to demonstrate the relative bioequivalence of ...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00857142
Treatments Being Tested
The purpose of this study is to evaluate the dose proportionality of the ph...
Status
Completed
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01800682
Treatments Being Tested
Bioequivalence between PPX ER 1.5 mg x 1 tablet q.d. and 0.375 mg PPX ER x ...
Status
Completed
Location
248.677.001 Boehringer Ingelheim Investigational Site
Start Date
2010-04
Trial ID
NCT01119443
The purpose of this study is to evaluate bio-equivalence of tapentadol exte...
Status
Completed
Location
Multiple Locations
Start Date
2010-07
Trial ID
NCT01900587
Treatments Being Tested
Determine and compare the plasma concentrations of Mucinex® Extended Releas...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-29
Trial ID
NCT03649750
Treatments Being Tested
The objective of this study is to compare the relative bioequivalence of a ...
Status
Completed
Location
Gateway Medical Research
Start Date
2002-09
Trial ID
NCT00840411
Treatments Being Tested
The purpose of this study is to compare the pharmacokinetics (PK) profiles ...
Status
Completed
Location
Parexel International
Start Date
2012-06
Trial ID
NCT01686217
Treatments Being Tested
Determine and compare the plasma concentrations and safety and tolerability...
Status
Completed
Location
Multiple Locations
Start Date
2007-05-05
Trial ID
NCT03642873
Treatments Being Tested